Clinical Research Directory

Inclusion Criteria: * Healthy male and female adults between ages 18-50 years, who are able and willing to provide written informed consent and will comply with the study requirements. * Already completed a primary course of COVID-19 immunisation (any World Health Organisation approved primary immunisation course is acceptable). Exclusion Criteria: * Unwilling or unable to provide written informed consent to take part * Unwilling or unable to comply with study procedures * Previously received an Ebola vaccine or previous exposure to Ebola virus (including serological and clinical diagnoses, irrespective of viral strain) * Not received a primary course of COVID-19 immunisation * History of any suspected or confirmed disorder of the immune system that, in the opinion of the Investigators, might impair the results of the study * Use of immunosuppressant medication within the past 6 months (excluding topical steroids or oral steroid courses lasting \<7 days) * Current diagnosis or treatment of cancer (unless non-melanomatous skin cancer) * Have a bleeding disorder deemed significant by study doctor * Pregnant or breast-feeding females * Able to avoid close contact with vulnerable individuals, including via high-risk blood and bodily fluids for 6 weeks following vaccination to reduce the risk of transmission to vulnerable individuals (e.g. immuno-compromised individuals, individuals receiving immunosuppressive therapy, pregnant or breast-feeding women, children \<1 year of age). * Unable to prevent contact of their blood or bodily fluids with farm animals in the 6 weeks following vaccination * Plan to donate blood in the 6 weeks following vaccination * Hypersensitivity to any active substances, excipients, or rice protein. * History of anaphylaxis to any component of vaccine formulation.